Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,283 public trials 441 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis

NCT01609049

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Altay Region Aids Center Barnaul, Russia
  • Barnaul City Hospital #5; Therapy Barnaul, Russia
  • Chelyabinsk State Medical Academy; Infectious Diseases Chelyabinsk, Russia
  • Chita State Medical Academy Chita, Russia
View all 57 locations
View Trial Details
Completed

An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin

NCT01392742

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Mhat - Pleven; Clinic of Gastroenterology Pleven, Bulgaria
  • Umhat St. Georgi; Clinical of Gastroenterology Plovdiv, Bulgaria
  • MHAT Tokuda Hospital Sofia; Department of Gastroenterology at Clinic of Internal Deseases Sofia, Bulgaria
  • UMHAT Alexandrovska EAD; Gastroenterology Sofia, Bulgaria
View Trial Details
Completed

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

NCT01011738

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Lkh-Univ. Klinikum Graz Graz, Austria
  • Tiroler Landeskrankenanstalten Ges.M.B.H.; Klinische Abt. Für Gaströnterologie & Hepatologie Innsbruck, Austria
  • A.Ö. Krankenhaus Der Elisabethinen Linz; Iv. Med. Abtl. Linz, Austria
  • Medizinische Universität Wien; Univ.Klinik für Innere Medizin III - Gastroenterologie & Hepatologie Vienna, Austria
View all 249 locations
View Trial Details
Completed

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

NCT01697501

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Azienda Ospedaliera Policlinico Consorziale di Bari; Clinica Malattie Infettive Bari, Apulia, Italy
  • Ospedale de Bellis; Reparto Medicina Generale Castellana Grotte, Apulia, Italy
  • Az. Osp. S. Sebastiano; Divisione Malattie Infettive Caserta, Campania, Italy
  • Az. Osp. Cardarelli; Unita Operativa A Struttura Complessa Di Epatologia Naples, Campania, Italy
View Trial Details
Completed

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy

NCT01416610

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Lkh Hoergas-Enzenbach; Abt. Für Innere Medizin Gratwein, Austria
  • Lkh-Univ. Klinikum Graz Graz, Austria
  • Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin Innsbruck, Austria
  • Klinikum Klagenfurt am Wörthersee; 2. Medizinische Abteilung Klagenfurt, Austria
View Trial Details
Completed

3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection

NCT01349465

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • Jacksonville, Florida, United States
View all 48 locations
View Trial Details
Completed

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

NCT01508130

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Cooper Green Hospital Birmingham, Alabama, United States
  • Univ. of Alabama at Birmingham; The Kirklin Clinic Birmingham, Alabama, United States
  • Liver Wellness Center Little Rock, Arkansas, United States
  • Loma Linda University Medical Center and Liver Center Loma Linda, California, United States
View all 66 locations
View Trial Details
Completed

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

NCT01667432

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Mhat - Pleven; Clinic of Gastroenterology Pleven, Bulgaria
  • Umhat St. Georgi; Clinical of Gastroenterology Plovdiv, Bulgaria
  • MHAT Tokuda Hospital Sofia; Department of Gastroenterology at Clinic of Internal Deseases Sofia, Bulgaria
  • UMHAT Alexandrovska EAD; Gastroenterology Sofia, Bulgaria
View Trial Details

Related conditions